Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F1M03
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,205
Award facts
- Contract value 100% obligated
- $61,205.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $61,205.06 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on December 3, 2025, with completion expected by December 4, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric/adult pharmaceutical supply requirement, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award carries no set-aside designation and operates as a child contract under the vendor's larger Indefinite Delivery Contract framework with DLA Troop Support Medical.
This delivery order is issued under AmerisourceBergen Drug Corp's existing $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and broader government healthcare system requirements. The firm's extensive federal contract portfolio demonstrates consistent capability to meet competitive procurement standards through the Defense Logistics Agency's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F1M03?
SPE2DR26F1M03 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F1M03 worth?
The government has obligated $61,205 on SPE2DR26F1M03.
Is contract SPE2DR26F1M03 an order under another contract?
Yes. SPE2DR26F1M03 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1M03 competed?
The extent of competition for SPE2DR26F1M03 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award